Innate Pharma
IPHA
#8397
Rank
โ‚น14.44 B
Marketcap
โ‚น169.32
Share price
2.06%
Change (1 day)
-24.23%
Change (1 year)

EPS for Innate Pharma (IPHA)

EPS in 2022: -โ‚น66.86

According to Innate Pharma 's latest financial reports the company's current EPS (TTM) is -โ‚น66.86. In 2022 the company made an earnings per share (EPS) of -โ‚น66.86 a decrease over its 2021 EPS that were of -โ‚น63.92.

EPS history for Innate Pharma from 2005 to 2022

Annual EPS

Year EPS Change
2022-โ‚น66.864.6%
2021-โ‚น63.92-24.98%
2020-โ‚น85.20186.89%
2019-โ‚น29.70-707.12%
2018โ‚น4.89-105.35%
2017-โ‚น91.37-541.28%
2016โ‚น20.70-270.34%
2015-โ‚น12.16-70.03%
2014-โ‚น40.56390.66%
2013-โ‚น8.27-8.65%
2012-โ‚น9.05-57.03%
2011-โ‚น21.06-48.58%
2010-โ‚น40.95-40.32%
2009-โ‚น68.6124.76%
2008-โ‚น54.9922.34%
2007-โ‚น44.9516.95%
2006-โ‚น38.43-7.23%
2005-โ‚น41.43